secwatch.observer — SEC 8-K summary ====================================== Issuer: Envista Holdings Corp (NVST) CIK: 0001757073 Form: 8-K Filed at: 2022-05-04T23:59:59+00:00 Accession: 0001757073-22-000060 Event type: earnings Sentiment: positive Materiality: 0.75 Item codes: 2.02, 7.01, 9.01 LLM model: deepseek-v4-flash:cloud@v2 Envista Q1 sales $631.4M, core growth 5.4%, completes IOS acquisition --------------------------------------------------------------------- - Q1 sales $631.4M (+3.1% as-reported, +5.4% core growth YoY). - GAAP diluted EPS $0.39; adjusted diluted EPS $0.47 vs $0.49 in Q1 2021. - Adjusted EBITDA $124.6M (19.7% margin) vs $132.3M prior year. - Completed acquisition of Carestream Dental's intraoral scanner business; expects $35-45M IOS sales in 2022. - FY2022 guidance: core sales growth 6-8%, adj. EBITDA margin >20%; Q2 mid-single digit core growth. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1757073/000175707322000060/0001757073-22-000060-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1757073/000175707322000060/nvst-20220504.htm HTML page: https://secwatch.observer/filing/0001757073-22-000060 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer